Form D · Biotechnology
Theromics Inc.
West Bridgewater, MA · CIK 0001745603
Offering snapshot reported May 9, 2023 · SEC filing
- Reported sold
- $1.08M Offering amount: $2M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Apr 28, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 9, 2023 | Initial | $1,077,000 | No comparison | 16 | SEC filing |
| Oct 16, 2020 | Initial | $1,005,000 | No comparison | 17 | SEC filing |
| Aug 23, 2019 | Initial | $125,000 | No comparison | 2 | SEC filing |
| Jul 6, 2018 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-481233
Source: Form D, filed May 9, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Amaral | Director |
| John Brooks | Director |
| Damian Dupuy | Director, Executive |
| Ronald Murphy | Director, Executive |
| William Keun Chan Park | Director, Executive |
| William Keun Chan Park | Director, Executive |
| Edward Walsh | Director, Executive |
| Charles R. Williams, Iii | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
375 West Street
West Bridgewater, MA, 02379
West Bridgewater, MA, 02379